Note: Supplemental materials are not guaranteed with Rental or Used book purchases.
Purchase Benefits
What is included with this book?
About the Editors XVII
List of Contributors XIX
Preface XXIII
1 The Design of Safer Chemicals: Past, Present, and Future Perspectives 1
Stephen C. DeVito
1.1 Evolution of the Concept 1
1.2 Characteristics of a ‘‘Safer Chemical’’ 9
1.3 The Future of the Concept 16
1.4 Disclaimer 18
References 18
2 Differential Toxicity Characterization of Green Alternative Chemicals 21
Richard Judson
2.1 Introduction 21
2.2 Chemical Properties Related to Differential Toxicity 23
2.3 Modeling Chemical Clearance – Metabolism and Excretion 25
2.4 Predicting Differential Inherent Molecular Toxicity 28
2.5 Integrating In Vitro Data to Model Toxicity Potential 31
2.6 Databases Relevant for Toxicity Characterization 33
2.7 Example of Differential Toxicity Analysis 34
2.8 Conclusion 39
2.9 Disclaimer 40
References 40
3 Understanding Mechanisms of Metabolic Transformations as a Tool for Designing Safer Chemicals 47
Thomas G. Osimitz and John L. Nelson
3.1 Introduction 47
3.2 The Role of Metabolism in Producing Toxic Metabolites 47
3.3 Mechanisms by Which Chemicals Produce Toxicity 59
3.4 Conclusion 69
References 72
4 Structural and Toxic Mechanism-Based Approaches to Designing Safer Chemicals 77
Stephen C. DeVito
4.1 Toxicophores 77
4.2 Designing Safer Electrophilic Substances 82
4.3 Structure–Activity Relationships 86
4.4 Quantitative Structure–Activity Relationships (QSARs) 92
4.5 Isosteric Substitution as a Strategy for the Design of Safer Chemicals 95
4.6 Conclusion 100
4.7 Disclaimer 102
References 102
5 Informing Substitution to Safer Alternatives 107
Emma Lavoie, David DiFiore, Meghan Marshall, Chuantung Lin, Kelly Grant, Katherine Hart, Fred Arnold, Laura Morlacci, Kathleen Vokes, Carol Hetfield, Elizabeth Sommer, Melanie Vrabel, Mary Cushmac, Charles Auer, and Clive Davies
5.1 Design for Environment Approaches to Risk Reduction: Identifying and Encouraging the Use of Safer Chemistry 107
5.2 Assessment of Safer Chemical Alternatives: Enabling Scientific, Technological, and Commercial Development 108
5.3 Informed Substitution 111
5.4 Examples that Illustrate Informed Substitution 116
5.5 Conclusion 132
5.6 Disclaimer 133
References 133
6 Design of Safer Chemicals – Ionic Liquids 137
Ian Beadham, Monika Gurbisz and Nicholas Gathergood
6.1 Introduction 137
6.2 Environmental Considerations 137
6.3 Ionic Liquids – a Historical Perspective 138
6.4 From Ionic Liquid Stability to Biodegradability 141
6.5 Conclusion 152
References 155
7 Designing Safer Organocatalysts – What Lessons Can Be Learned When the Rebirth of an Old Research Area Coincides with the Advent of Green Chemistry? 159
Ian Beadham, Monika Gurbisz and Nicholas Gathergood
7.1 Introduction 159
7.2 A Brief History of Organocatalysis 159
7.3 Catalysts from the Chiral Pool 163
7.4 ‘‘Rules of Thumb’’ for Small Molecule Biodegradability Applied to Organocatalysts 167
7.5 Cinchona Alkaloids – Natural Products as a Source of Organocatalysts: Appendix 7.A 174
7.6 Proline, the Most Extensively Studied Organocatalyst: Appendix 7.B 175
7.7 Process of Catalyst Development 177
7.8 Analogs of Nornicotine – an Aldol Catalyst Exemplifying ‘‘Natural’’ Toxicity 179
7.9 Pharmaceutically Derived Organocatalysts and the Role of Cocatalysts 180
7.10 Conclusion 185
7.11 Summary 185
References 221
8 Life-Cycle Concepts for Sustainable Use of Engineered Nanomaterials in Nanoproducts 227
Bernd Nowack, Fadri Gottschalk, Nicole C. Mueller and Claudia Som
8.1 Introduction 227
8.2 Life-Cycle Perspectives in Green Nanotechnologies 228
8.3 Release of Nanomaterials from Products 230
8.4 Exposure Modeling of Nanomaterials in the Environment 237
8.5 Designing Safe Nanomaterials 243
8.6 Conclusion 245
References 245
9 Drugs 251
Klaus Kümmerer
9.1 Introduction 251
9.2 Pharmaceuticals – What They Are 251
9.3 Pharmaceuticals in the Environment – Sources, Fate, and Effects 252
9.4 Risk Management 257
9.5 Designing Environmentally Safe Drugs 259
9.6 Conclusion 271
References 272
10 Greener Chelating Agents 281
Nicholas J. Dixon
10.1 Introduction 281
10.2 Chelants 282
10.3 Common Chelants 284
10.4 Issues with Current Chelants 285
10.5 Green Design Part 1 – Search for Biodegradable Chelants 290
10.6 Comparing Chelating Agents 293
10.7 Six Steps to Greener Design 299
10.8 Case Study – Six Steps to Greener Chelants for Laundry 302
10.9 Conclusion 305
10.10 Abbreviations 305
References 306
11 Improvements to the Environmental Performance of Synthetic-Based Drilling Muds 309
Sajida Bakhtyar and Marthe Monique Gagnon
11.1 Introduction 309
11.2 Drilling Mud Composition 310
11.3 Characteristics and Biodegradability of SBFs 312
11.4 Case Study: Improvements in the Environmental Performance of Synthetic-Based Drilling Muds 314
11.5 Conclusion 323
References 323
12 Biochemical Pesticides: Green Chemistry Designs by Nature 329
Russell S. Jones
12.1 Introduction 329
12.2 The Historical Path to Safer Pesticides 329
12.3 Reduced-Risk Conventional Pesticides 331
12.4 The Biopesticide Alternative: an Overview 331
12.5 Biochemical Pesticides 333
12.6 Are Biochemical Pesticides the Wave of the Future? 340
12.7 Conclusion 343
12.8 Disclaimer 343
References 344
13 Property-Based Approaches to Design Rules for Reduced Toxicity 349
Adelina Voutchkova, Jakub Kostal, and Paul Anastas
13.1 Possible Approaches to Systematic Design Guidelines for Reduced Toxicity 349
13.2 Analogy with Medicinal Chemistry 354
13.3 Do Chemicals with Similar Toxicity Profiles Have Similar Physical/Chemical Properties? 356
13.4 Proposed Design Guidelines for Reduced Human Toxicity 358
13.5 Using Property Guidelines to Design for Reducing Acute Aquatic Toxicity 362
13.6 Predicting the Physicochemical Properties and Attributes Needed for Developing Design Rules 365
13.7 Conclusion 371
References 371
14 Reducing Carcinogenicity and Mutagenicity Through Mechanism-Based Molecular Design of Chemicals 375
David Y. Lai and Yin-tak Woo
14.1 Introduction 375
14.2 Mechanisms of Chemical Carcinogenesis and Structure–Activity Relationship (SAR) 376
14.3 General Molecular Parameters Affecting the Carcinogenic and Mutagenic Potential of Chemicals 378
14.4 Specific Structural Criteria of Different Classes of Chemical Carcinogens and Mutagens 382
14.5 Molecular Design of Chemicals of Low Carcinogenic and Mutagenic Potential 398
14.6 Conclusion 403
14.7 Disclaimer 404
References 404
15 Reducing Ecotoxicity 407
Keith R Solomon and Mark Hanson
15.1 Introduction to Key Aspects of Ecotoxicology 407
15.2 Environmental Fate and Pathways of Exposure to Chemicals in the Environment 413
15.3 Mechanisms of Toxic Action 419
15.4 Examples of Methods That Can Be Used in Designing Chemicals with Reduced Ecological Risks 424
15.5 Overview, Conclusions, and the Path Forward 437
References 440
16 Designing for Non-Persistence 453
Philip H. Howard and Robert S. Boethling
16.1 Introduction 453
16.2 Finding Experimental Data 454
16.3 Predicting Biodegradation from Chemical Structure 461
16.4 Predicting Chemical Hydrolysis 467
16.5 Predicting Atmospheric Degradation by Oxidation and Photolysis 469
16.6 Designing for Biodegradation I: Musk Fragrances Case Study 470
16.7 Designing for Biodegradation II: Biocides Case Study 472
16.8 Designing for Abiotic Degradation: Case Studies for Hydrolysis and Atmospheric Degradation 477
16.9 Conclusion 479
16.10 Disclaimer 479
Abbreviations 480
References 480
17 Reducing Physical Hazards: Encouraging Inherently Safer Production 485
Nicholas A. Ashford
17.1 Introduction 485
17.2 Factors Affecting the Safety of a Production System [1] 485
17.3 Chemical Safety and Accident Prevention: Inherent Safety and Inherently Safer Production 488
17.4 Incentives, Barriers, and Opportunities for the Adoption of Inherently Safer Technology 491
17.5 Elements of an Inherently Safer Production Approach [2, 3] 493
17.6 A Methodology for Inherently Safer Production 495
References 499
18 Interaction of Chemicals with the Endocrine System 501
Thomas G. Osimitz
18.1 Interaction with the Endocrine System 501
18.2 Estrogens 504
18.3 Androgens 515
18.4 Hypothalamic-Pituitary-Thyroid (HPT) Axis 516
18.5 Endocrine Disruptor Data Development Efforts 519
18.6 Research Needs and Future 521
References 522
Index 525
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.